MetaCap

Exicure Inc. Company Profile

NASDAQ: XCURHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.989-0.021 (-2.13%)

Market open · Delayed 15 min · as of Oct 9, 1:11 PM ET

Exicure at a glance

Exicure Inc. (NASDAQ: XCUR) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Redwood City, CA. Exicure is led by Mr. Jungsoo Kim and employs about 1 people. At a market capitalization of $6.7 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001698530, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Exicure do?

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

Business description based on the company's public filings.

Company information

Legal name
Exicure Inc.
Ticker
NASDAQ: XCUR
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Jungsoo Kim
Employees
1
Headquarters
400 Seaport Court, Redwood City, CA, United States
Phone
847 673 1700
Website
exicuretx.com
Market cap
$6.68M
SEC CIK
0001698530
Latest annual report
10-K · Mar 25, 2026

Companies similar to Exicure

XCUR peer companies
CompanyPrice% ChgMarket capCompare
ALZNAlzamend Neuro Inc.1.36+1.49%$6.56Mvs XCUR
TRAWTraws Pharma Inc.0.4443-7.50%$6.83Mvs XCUR
ENVBEnveric Biosciences Inc.1.44-5.19%$6.45Mvs XCUR
APUSApimeds Pharmaceuticals US Inc.4.64-15.79%$7.00Mvs XCUR
SCNXScienture Holdings Inc.3.84-0.52%$6.31Mvs XCUR
ACXPAcurx Pharmaceuticals Inc.1.27+1.61%$7.06Mvs XCUR
NRSNNeuroSense Therapeutics Ltd.3.84+2.67%$7.28Mvs XCUR
CANFCan-Fite Biopharma Ltd ADR1.99-0.50%$6.03Mvs XCUR

Related